# Frequent Gastrointestinal Cancer Complications in Japanese Patients with Acute or Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention

**Authors:** Yasuyuki Chiba, Shogo Imagawa, Yuki Takahashi, Kimitoshi Kubo, Kenta Otsuka, Kyo Shimazu, Teisuke Anzai, Kazuya Yonezawa, Mototsugu Kato, Toshihisa Anzai

PMC · DOI: 10.3390/jcm14061807 · Journal of Clinical Medicine · 2025-03-07

## TL;DR

Many Japanese patients undergoing heart procedures also have gastrointestinal cancers, which can be detected through endoscopy without affecting survival outcomes.

## Contribution

Highlights the high prevalence of gastrointestinal malignancies in Japanese PCI patients and the value of endoscopic evaluation.

## Key findings

- 8% of patients undergoing PCI had gastrointestinal malignancies, including colorectal and gastric cancers.
- Fecal immunochemical testing detected some but not all malignancies.
- Endoscopic evaluation during PCI did not worsen survival and could lead to timely cancer treatment.

## Abstract

Background/Objective: Gastrointestinal bleeding is a major complication of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Malignancy may be detected due to gastrointestinal bleeding, necessitating critical decisions regarding treatment selection and influencing patient prognosis. Methods: This single-center, retrospective, observational study included 501 Japanese patients who underwent initial PCI between January 2019 and January 2023. Of these patients, 393 who underwent perioperative upper and lower gastrointestinal endoscopy were evaluated for the presence of gastrointestinal malignancy. Results: Of the total patients, 36% presented with acute coronary syndrome (ACS). Gastrointestinal malignancies were identified in 30 patients (8%), including 18 cases of colorectal cancer and eight cases of gastric cancer. No difference in the frequency of malignancies was observed between patients with ACS and chronic coronary syndrome (CCS) (p = 0.7398). Malignancies were significantly more common in patients with positive fecal immunochemical testing (FIT) (p < 0.0001); however, FIT did not detect all malignancies. The 1500-day survival rate for patients with gastrointestinal malignancies was 64%, with no difference in overall survival between treatment modalities. Conclusions: A considerable proportion of Japanese patients undergoing PCI had gastrointestinal malignancies, regardless of whether they had ACS or CCS, and their prognosis was poor. Gastrointestinal endoscopic evaluation in the perioperative period of PCI could detect malignancy without complications and might lead to appropriate cancer treatment.

## Linked entities

- **Diseases:** acute coronary syndrome (MONDO:0005542), colorectal cancer (MONDO:0005575), gastric cancer (MONDO:0001056)

## Full-text entities

- **Diseases:** Gastrointestinal Cancer Complications (MESH:D005770), Gastrointestinal bleeding (MESH:D006471), colorectal cancer (MESH:D015179), ACS (MESH:D054058), Malignancies (MESH:D009369), gastric cancer (MESH:D013274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11943319/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11943319/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC11943319/full.md

---
Source: https://tomesphere.com/paper/PMC11943319